Overcoming the barriers to treatment of multi-drug resistant Gram-negative bloodstream infections in Australian children

克服澳大利亚儿童多重耐药革兰氏阴性血流感染的治疗障碍

• 批准号: nhmrc : 1197743
• 金额: $ 44.76万
• 依托单位国家: 澳大利亚
• 项目类别: Investigator Grants
• 财政年份: 2020
• 资助国家: 澳大利亚
• 起止时间: 2020-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/overcoming-barriers-treatment-australian-children/1779327
• 关键词: Overcoming; barriers; treatment; multi; drug

There is a critical need to develop new treatments for children with antibiotic resistant infections. The most important bacteria causing resistant infections are known as Gram-negative bacteria. Doctors treating children with resistant Gram-negative infections are faced with few antibiotic options. This project will discover the most important resistant infections in Australian children, and trial a new antibiotic to help doctors to use it in the right children and at the right dose.

迫切需要为患有抗生素耐药性感染的儿童开发新的治疗方法。引起耐药感染的最重要的细菌是已知的革兰氏阴性细菌。治疗耐药革兰氏阴性感染的儿童的医生面临的抗生素选择很少。该项目将发现澳大利亚儿童中最重要的耐药感染，并试验一种新的抗生素，以帮助医生在正确的儿童和正确的剂量下使用它。